Skip to the page

Data / Form D filings / EnClear Therapies, Inc.

EnClear Therapies, Inc.: Form D filing

EnClear Therapies, Inc., a company in Cambridge, MA, filed a Form D with the SEC in 2024. The latest, on March 1, 2024, reports $718,331 sold of a $2 million offering to 8 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
700 MAIN STREET, Cambridge, MA, 02139
Phone
(603) 343-8504
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1766406

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 1, 2024New notice$1,999,996$718,331$1,281,6658Feb 22, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jonathan FlemingDirector
Jason CammDirector
Kasper RoetDirector
Anthony DePasquaExecutive Officer, Director

Other companies in Massachusetts that filed recently

Every Form D from the week of Feb 26, 2024 · All recent filings in Massachusetts · All recent Other filings

Read from SEC EDGAR. Amount sold is what EnClear Therapies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.